In turn, the inhibition of the two interactions of DDIT3 identified by MuXTalk, CUL1 and EP300, has been shown to reduce fibroblast proliferation in chronic obstructive pulmonary disease (COPD) and IPF (53,54). Here, DDIT3 is linked to chronic obstructive pulmonary disease.